BAJAJ BROKING

Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

543916

HSIL

img img img img
No Data Available

Hemant Surgical Industries Lim Share Price Update

As of the latest trading session, Hemant Surgical Industries Lim share price is currently at ₹ 260, which is up by ₹ 0.35 from its previous closing. Today, the stock has fluctuated between ₹ 247.50 and ₹ 262.00. Over the past year, Hemant Surgical Industries Lim has achieved a return of 105.17 %. In the last month alone, the return has been -3.86 %. Read More...

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Hemant Surgical Industries Lim fundamentals


  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text
  • Market cap (Cr)

    337.70

  • P/E Ratio (TTM)

    41.61

  • Beta

    0.68

  • Book Value / share

    87.57

  • Return on equity

    13.80%

  • EPS (TTM)

    6.14

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    0.00

info icon alternate text

Hemant Surgical Industries Lim Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars MAR 2025 (Values in Cr)
Revenue 106.53
Operating Expense 101.08
Net Profit 8.13
Net Profit Margin (%) 7.63
Earnings Per Share (EPS) 7.79
EBITDA 14.18
Effective Tax Rate (%) 22.91
Particulars MAR 2024 (Values in Cr)
Revenue 105.61
Operating Expense 97.13
Net Profit 9.80
Net Profit Margin (%) 9.27
Earnings Per Share (EPS) 9.85
EBITDA 14.78
Effective Tax Rate (%) 23.31
Particulars MAR 2023 (Values in Cr)
Revenue 109.15
Operating Expense 101.44
Net Profit 7.64
Net Profit Margin (%) 6.99
Earnings Per Share (EPS) 10.26
EBITDA 12.82
Effective Tax Rate (%) 24.05
Particulars MAR 2025 (Values in Cr)
Book Value / Share 60.51
ROE % 12.73
ROCE % 13.50
Total Debt to Total Equity 0.49
EBITDA Margin 13.33
Particulars MAR 2025 (Values in Cr)
Book Value / Share 60.34
ROE % 13.80
ROCE % 16.47
Total Debt to Total Equity 0.32
EBITDA Margin 13.43
Particulars MAR 2024 (Values in Cr)
Book Value / Share 52.55
ROE % 25.06
ROCE % 29.63
Total Debt to Total Equity 0.18
EBITDA Margin 13.99
Particulars MAR 2023 (Values in Cr)
Book Value / Share 30.41
ROE % 41.85
ROCE % 44.65
Total Debt to Total Equity 0.46
EBITDA Margin 11.82
Particulars MAR 2022 (Values in Cr)
Book Value / Share 65.74
ROE % 39.22
ROCE % 32.28
Total Debt to Total Equity 1.03
EBITDA Margin 8.21
Particulars MAR 2021 (Values in Cr)
Book Value / Share 455.64
ROE % 15.47
ROCE % 13.58
Total Debt to Total Equity 1.61
EBITDA Margin 6.72
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 9.54
Total Assets 148.30
Total Liabilities 148.30
Total Equity 63.17
Share Outstanding 10440000
Price to Book Ratio 1.65
Return on Assets (%) 5.42
Return on Capital (%) 8.54
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 9.45
Total Assets 147.64
Total Liabilities 147.64
Total Equity 62.99
Share Outstanding 10440000
Price to Book Ratio 1.65
Return on Assets (%) 5.50
Return on Capital (%) 8.67
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 13.17
Total Assets 100.04
Total Liabilities 100.04
Total Equity 54.85
Share Outstanding 10440000
Price to Book Ratio 2.53
Return on Assets (%) 9.79
Return on Capital (%) 15.91
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 8.45
Total Assets 64.69
Total Liabilities 64.69
Total Equity 23.35
Share Outstanding 7680000
Price to Book Ratio 0.00
Return on Assets (%) 11.80
Return on Capital (%) 25.06
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 5.82
Total Assets 54.37
Total Liabilities 54.37
Total Equity 13.14
Share Outstanding 2000000
Price to Book Ratio 0.00
Return on Assets (%) 8.48
Return on Capital (%) 20.16
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 2.44
Total Assets 40.30
Total Liabilities 40.30
Total Equity 10.36
Share Outstanding 200000
Price to Book Ratio 0.00
Return on Assets (%) 3.36
Return on Capital (%) 5.46
Particulars MAR 2025 (Values in Cr)
Net Income 10.46
Cash from Operations 10.76
Cash from Investing -30.27
Cash from Financing 17.64
Net change in Cash -3.79
Free Cash Flow 49.50
Particulars MAR 2025 (Values in Cr)
Net Income 10.55
Cash from Operations 11.57
Cash from Investing -30.27
Cash from Financing 17.64
Net change in Cash -3.71
Free Cash Flow 50.41
Particulars MAR 2024 (Values in Cr)
Net Income 12.78
Cash from Operations -0.93
Cash from Investing -12.37
Cash from Financing 21.23
Net change in Cash 4.71
Free Cash Flow 8.13
Particulars MAR 2023 (Values in Cr)
Net Income 10.05
Cash from Operations 8.83
Cash from Investing -2.97
Cash from Financing -0.69
Net change in Cash 2.63
Free Cash Flow 12.76
Particulars MAR 2022 (Values in Cr)
Net Income 6.11
Cash from Operations 12.41
Cash from Investing -0.05
Cash from Financing -7.70
Net change in Cash 4.30
Free Cash Flow 12.83
Particulars MAR 2021 (Values in Cr)
Net Income 1.48
Cash from Operations -3.92
Cash from Investing -2.27
Cash from Financing 4.95
Net change in Cash -1.75
Free Cash Flow -1.53
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7326.30 63.01 11.59 105340.95 6002.15 / 8099.00
FORTIS MALAR HOSPITALS LIMITED 63.58 26.27 3.46 119.16 53.30 / 98.70
SHREE PACETRONIX LTD. 237.00 39.83 5.08 92.43 61.11 / 283.15
TRANSGENE BIOTEK LTD. 3.66 0.00 3.01 27.73 3.21 / 8.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7326.30 75.15 11.30 105340.95 6002.15 / 8099.00
Surlux Diagnostic Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 45.00 0.00 -13.07 33.62 28.34 / 59.90
KOVAI MEDICAL CENTER & HOSPITA 5974.80 28.59 5.49 6536.43 4810.20 / 6725.00

Hemant Surgical Industries Lim shareholding pattern

Holding

30.13%
58.9%
0.15%
10.8%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

Transparent Pricing and 360° Services

Choose a Plan That Suits Your Goals and Needs

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : ₹2,500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% on Delivery 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Stock Picks by Research Analysts tick Experienced Dealer Support

Hemant Surgical Industries Lim Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
259.00 -0.25 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 265.30
  • 26 Days 282.50
  • 10 Days 271.80
  • 50 Days 283.10
  • 12 Days 273.70
  • 100 Days 257.70
  • 20 Days 279.50
  • 200 Days 216.60
256.50 PIVOT

First Support

253.15

First Resistance

263.00

Second Support

246.65

Second Resistance

266.35

Third Support

243.30

Third Resistance

272.85

RSI

31.75

ADX

54.07

MACD

-8.74

Williams % R

-80.70

Commodity Channel Index (CCI)

-182.22

Date

2025-11-27

Week

7400.00

Same Day

18800.00

Month

9704.00

1 Year

0.69

3 Year

0.54

Over 1 Month

-3.86%

down

Over 1 Year

105.17%

down

Over 3 Months

-12.42%

down

Over 3 Years

13.08%

down

Over 6 Months

147.28%

down

Over 5 Years

0.00%

down

Hemant Surgical Industries Lim Corporate Actions

Hemant Surgical Industries Lim Share Price

Hemant Surgical Industries Limited was originally incorporated as 'Hemant Surgical Industries Private Limited' dated March 27, 1989, by ROC, Mumbai. Subsequently, Company was converted into a public limited company and the name of Company was changed to 'Hemant Surgical Industries Limited' vide fresh Certificate of Incorporation dated February 22, 1994 by the Registrar of Companies, Mumbai.

Company is in the business of Medical Equipment & Supplies in Mumbai. Its product basket cover a wide spectrum of equipments and disposables required for Renal Care, Cardiovascular Disease, Respiratory Disease, Critical Care and Radiology and Surgical disposables. In addition, the Company is providing services for maintenance and in running of 5 dialysis centres.

The Company started its operations in 1993 with importing and marketing of medical disposables like meditapes, all over India from JMS Co Ltd. Japan. Later in year 1999, it started the operations by expanding manufacturing plant at Achhad, Maharashtra for external preparation and Small Volume Parentals. The Company is currently manufacturing products like Dialysis solution (liquid and Powder) used in dialysis, Hot and Cold Sterilant used for cleaning dialyzer, Purified water used in rinsing and cleaning of dialysis machines and sanitizer.

Assembly Unit II situated at Atgaon is used in various medical devices like Nebulizers, Oxygen Concentrator, Air Mattress, Digital Thermometer, Pulse Oximeters, ECG Electrodes, Dialyzer which are sold under the Brand Name 'Aero Plus'. Assembly Unit III at Bhiwandi is used in products like Intravenous Infusion Set, ECG Machines, Ultrasound Machines, Paramonitor, Ventilator etc.

Later, in 2022, the Company got into a distribution agreement with JMS Co. Ltd., Japan for importing and marketing JMS Meditape in India, with JMS Singapore Pte. Ltd. for manufacturing Intravenous Infusion Set. The Company was appointed as sole agent of SWS Hemodialysis Care Co. Ltd. China to sell and do maintenance of SWS-4000A hemodialysis machines in West India. It signed distribution agreement with Hemant Phillipines Inc. for supply in renal care equipment, medical devices and consumables for marketing the same in Philippines, with Zoncare Bio-medical Electronics Co., Ltd for radiology and assembly of critical care products like Ultrasound Machine.

The Company issued its securities via Initial Public Offering of 27,60,000 Equity Shares by raising funds of Rs 25 Cr in May, 2023.

Parent organization Indian Private
NSE symbol [-]
Founded 1989
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Hemant Surgical Industries Ltd?

Answer Field

Hemant Surgical Industries Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 259.00 as on Nov 28 2025 03:25 PM.

What is the Market Cap of Hemant Surgical Industries Ltd Share?

Answer Field

The market cap of Hemant Surgical Industries Ltd for NSE ₹ 0.00 & for BSE ₹ 337.70 as on Nov 28 2025 03:25 PM.

What is the 52 Week High and Low of Hemant Surgical Industries Ltd?

Answer Field

The 52 Week High and Low of Hemant Surgical Industries Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 367.10 and ₹ 88.15.

What is 1 year return for Hemant Surgical Industries Ltd?

Answer Field

The 1 year returns on the stock has been 105.17%.

What is the P/E Ratio of Hemant Surgical Industries Ltd Share?

Answer Field

As on Nov 28 2025 03:25 PM the price-to-earnings (PE) ratio for Hemant Surgical Industries Ltd share is 41.61.

What is the PB ratio of Hemant Surgical Industries Ltd Share?

Answer Field

As on Nov 28 2025 03:25 PM, the price-to-book (PB) ratio for Hemant Surgical Industries Ltd share is 87.57.

How to Buy Hemant Surgical Industries Ltd Share?

Answer Field

You can trade in Hemant Surgical Industries Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Hemant Surgical Industries Ltd Share on Bajaj Broking App?

Answer Field

To buy Hemant Surgical Industries Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Hemant Surgical Industries Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59